Zentiva, a.s. (BSSE:1SKF401E)

Market Cap	48.93M
Revenue (ttm)	36.17M
Net Income (ttm)	2.29M
Shares Out	1.62M
EPS (ttm)	1.41
PE Ratio	21.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	6
Open	30.20
Previous Close	30.00
Day's Range	30.20 - 30.20
52-Week Range	24.00 - 45.00
Beta	-0.45
RSI	47.52
Earnings Date	n/a

About Zentiva, a.s.

Zentiva, a.s. develops, manufactures, and sells generic medicinal products, primarily used in primary care sector in Slovak, Czech Republic, and internationally. The company offers prescription medicines. It also engages in the production and wholesaling of pharmaceuticals and chemical products. The company sells 56 pharmaceutical forms in Slovakia. Its portfolio includes lipid lowering agaents, hypothensive, sympatholytic, prokinetics, vitamins, antipyretics, beta- blockers, otorinolaryngol, antidiabetics, and anthistamines products. The compa...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 90
• Stock Exchange: Bratislava Stock Exchange
• Ticker Symbol: 1SKF401E

Financial Performance

In 2018, Zentiva, a.s.'s revenue was 36.17 million, a decrease of -74.65% compared to the previous year's 142.68 million. Earnings were 2.29 million, a decrease of -97.06%.